36 filings
8-K
CMPX
Compass Therapeutics Inc
13 May 24
Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
8:00am
8-K
CMPX
Compass Therapeutics Inc
25 Apr 24
Regulation FD Disclosure
8:00am
8-K
CMPX
Compass Therapeutics Inc
21 Mar 24
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
9:00am
8-K
CMPX
Compass Therapeutics Inc
9 Jan 24
Departure of Directors or Certain Officers
5:30pm
8-K
CMPX
Compass Therapeutics Inc
5 Jan 24
Compass Therapeutics Provides Corporate Update
8:00am
8-K
8m7xsp4as aby9d4d
9 Nov 23
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:30am
8-K
hblwk746
3 Aug 23
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:00am
8-K
hrr7zxony8w5 qy41wq
15 Jun 23
Submission of Matters to a Vote of Security Holders
11:15am
8-K
sviee4aekr iopt
4 May 23
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
8:30am
8-K
36r5mnl62c9pv 3r6
24 Apr 23
Departure of Directors or Certain Officers
4:30pm
8-K
wf083
10 Mar 23
Regulation FD Disclosure
11:56am
8-K
ckoe zyxg8bx1i745
24 Feb 23
Departure of Directors or Certain Officers
4:01pm
8-K
dhqzs
10 Feb 23
Departure of Directors or Certain Officers
4:00pm
8-K
1qk36q
19 Jan 23
Other Events
5:00pm
8-K
bmvjv 5u83m4y
29 Nov 22
Departure of Directors or Certain Officers
4:06pm
8-K
8nbi4jtu
2 Nov 22
Compass Therapeutics Announces $80 Million Private Placement
5:00pm
8-K
pri5v1so ld683x6e
19 Aug 22
Departure of Directors or Certain Officers
4:00pm
8-K
pp2eg8frt7 1t
1 Aug 22
Entry into a Material Definitive Agreement
8:20am
8-K
lmtvtoi x7knw9w005
31 May 22
Submission of Matters to a Vote of Security Holders
1:41pm
8-K
hqw7656az2ueue ptz
4 May 22
Compass Therapeutics Reports Positive Interim Phase 2 Data of CTX-009 in Combination with Paclitaxel in Biliary Tract Cancers
7:00am